- In April 2025, Candela Corporation, a global leader in energy-based medical aesthetics, announced the launch of the Vbeam Pro, the only vascular laser FDA-cleared for use in pediatric patients, which integrates a 595 nm pulsed dye laser with a 1064 nm Nd:YAG wavelength to deliver enhanced precision and versatility in treatment
- In June 2024, Lumenis Be Ltd. introduced FoLix™, its FDA-approved proprietary fractional laser system designed for the treatment of hair loss, offering non-invasive results in 4–6 monthly sessions without the need for needles, surgery, or chemicals
- In April 2024, Hahn & Company announced the initiation of a merger process between Lutronic and Cynosure following the acquisition of Cynosure, forming the new parent company Cynosure Lutronic, Inc., aimed at combining resources and innovation to serve the aesthetic industry
- In April 2024, CUTERA, INC., a top provider of aesthetic and dermatological technologies, announced the launch of xeo+, a next-generation laser and light-based multi-application platform that builds on the company’s legacy of innovation and high performance
